HIGHLIGHTS
- who: Claudia Omarini from the (UNIVERSITY) have published the article: T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis, in the Journal: (JOURNAL)
- what: The authors focused on the activity of T-DM1 in u00ad2nd line setting following TP and taxane u00ad1st line treatment.
- how: The authors collected all studies already published as full-text articles regarding the efficacy of T-DM1 in TP pre-treated HER2 positive MBC patients..
SUMMARY
Data from the Phase III TH3RESA study confirmed T-DM1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.